Literature DB >> 8324134

Bacteriologic findings in peritonsillar abscesses in young adults.

H Jousimies-Somer1, S Savolainen, A Mäkitie, J Ylikoski.   

Abstract

Aspirated pus samples from 124 patients with peritonsillar abscess were cultured quantitatively for aerobes and anaerobes. A total of 98% of the samples yielded bacteria. Of the 550 isolates obtained (mean, 4.4 per patient), 143 were aerobes (representing 16 species or groups) and 407 were anaerobes (representing 40 species or groups). Aerobes were isolated from 86% of patients-alone in 20 cases and together with anaerobes in 87. The most common aerobic isolates were Streptococcus pyogenes (isolated from 45% of patients), Streptococcus milleri group organisms (27%), Haemophilus influenzae (11%), and viridans streptococci (11%). Anaerobes were isolated from 82% of the samples and as a sole finding from 15 abscesses. Fusobacterium necrophorum and Prevotella melaninogenica were both isolated from 38% of patients, Prevotella intermedia from 32%, Peptostreptococcus micros from 27%, Fusobacterium nucleatum from 26%, and Actinomyces odontolyticus from 23%. The rate of previous tonsillar/peritonsillar infections was lowest (25%) among patients infected with S. pyogenes and highest (52%) among those infected with F. necrophorum (P < .01). Recurrences and/or related tonsillectomies were more common among patients infected with F. necrophorum than among those infected with S. pyogenes (57% vs. 19%; P < .0001) or with S. milleri group organisms (43% vs. 19%; P < .05). beta-Lactamase was produced by only 38% of the 73 isolates of Prevotella species tested; however, 56% of the 36 patients studied harbored one or more such strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324134     DOI: 10.1093/clinids/16.supplement_4.s292

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  40 in total

1.  Antibiotic resistance in bacteria isolated from subgingival plaque in a norwegian population with refractory marginal periodontitis.

Authors:  Trude Handal; Dominique A Caugant; Ingar Olsen
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

2.  Lemierre's syndrome: a rare cause of septic polyarthritis.

Authors:  Muhammad K Nisar; Anoop V Kuttikat; Balaji Ramabhadran; Daniel Fishman
Journal:  Rheumatol Int       Date:  2011-12-22       Impact factor: 2.631

3.  Efficient gene transfer and targeted mutagenesis in Fusobacterium nucleatum.

Authors:  Susan Kinder Haake; Sean Yoder; Sharon Hunt Gerardo
Journal:  Plasmid       Date:  2005-08-22       Impact factor: 3.466

4.  Significant pathogens in peritonsillar abscesses.

Authors:  T E Klug; J-J Henriksen; K Fuursted; T Ovesen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-22       Impact factor: 3.267

5.  Variations in the microbiology of peritonsillar abscess.

Authors:  H Gavriel; T Lazarovitch; A Pomortsev; E Eviatar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-09       Impact factor: 3.267

6.  Fusobacterial infections in children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

7.  Bacteriology of peritonsillar abscess in patients over 40 years--a neglected age group.

Authors:  Haim Gavriel; Yitzhak Golan; Tsilia Lazarovitch; Ephraim Eviatar
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-08       Impact factor: 2.503

8.  Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess.

Authors:  T E Klug; J-J Henriksen; M Rusan; K Fuursted; K A Krogfelt; T Ovesen; C Struve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-09       Impact factor: 3.267

9.  [Trends and complications in the management of peritonsillar abscess with emphasis on children].

Authors:  J P Windfuhr; S Remmert
Journal:  HNO       Date:  2005-01       Impact factor: 1.284

10.  Localised Fusobacterium necrophorum infections: a prospective laboratory-based Danish study.

Authors:  L Hagelskjaer Kristensen; J Prag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-14       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.